Literature DB >> 15978174

Minor inflammation after surgical evacuation compared with fibrinolytic therapy of experimental intracerebral hemorrhages.

Ruth Thiex1, Wilhelm Küker, P Jungbluth, C Kayser, Harald D Müller, Ina Rohde, Joachim M Gilsbach, Veit Rohde.   

Abstract

OBJECTIVES: Toxic components released from the intracerebral blood clot, such as thrombin and hemoglobin, potentially trigger brain edema formation and therefore favor an early evacuation of the clot. Despite a significant reduction in hematoma size in our porcine model of hematoma induction by injecting autologous blood ICP-controlled into the right frontal white matter with subsequent fibrinolysis using recombinant tissue-plasminogen activator (rt-PA) and aspiration of the liquefied clot (n = 9), local rt-PA promoted delayed perihematomatous edema formation and invoked a substantial inflammatory reaction compared with controls (n = 11).
METHODS: We therefore modified our formerly developed porcine model of intracerebral hemorrhage in removing the hematoma by open craniotomy and suction of the clot in seven animals. The residual hematoma size and extent of perifocal edema were evaluated over 10 days on planimetry of the MRI data, and correlated to the histopathological changes of edema and inflammation found at autopsy.
RESULTS: The edema volume on day 4 was significantly less in the surgical group compared with the lysis group (p < 0.03). On day 10, however, the difference in edema size was not statistically significant compared with the lysis group (p < 0.07) and the control group (p < 0.09). The inflammatory response was minor compared with the lysis and control group. DISCUSSION: In conclusion, despite a significant reduction in hematoma size by surgical removal of the clot, only the inflammatory response, but not the extent of delayed edema can be positively influenced.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978174     DOI: 10.1179/016164105X17369

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  8 in total

Review 1.  Intracerebral haemorrhage: mechanisms of injury and therapeutic targets.

Authors:  Richard F Keep; Ya Hua; Guohua Xi
Journal:  Lancet Neurol       Date:  2012-06-13       Impact factor: 44.182

Review 2.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

Review 3.  A review of stereotaxy and lysis for intracranial hemorrhage.

Authors:  Uzma Samadani; Veit Rohde
Journal:  Neurosurg Rev       Date:  2008-10-01       Impact factor: 3.042

4.  Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema.

Authors:  J Ricardo Carhuapoma; Ryan J Barrett; Penelope M Keyl; Daniel F Hanley; Robert R Johnson
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 5.  Progress in translational research on intracerebral hemorrhage: is there an end in sight?

Authors:  Guohua Xi; Jennifer Strahle; Ya Hua; Richard F Keep
Journal:  Prog Neurobiol       Date:  2013-10-16       Impact factor: 11.685

Review 6.  Preclinical models of intracerebral hemorrhage: a translational perspective.

Authors:  Michael Lucas James; David S Warner; Daniel T Laskowitz
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

7.  Tissue plasminogen activator induced delayed edema in experimental porcine intracranial hemorrhage: reduction with plasminogen activator inhibitor-1 administration.

Authors:  Naureen Keric; Gerrit Steffen Maier; Uzma Samadani; Kai Kallenberg; Peter Dechent; Wolfgang Brueck; Jan Heuer; Veit Rohde
Journal:  Transl Stroke Res       Date:  2012-05-26       Impact factor: 6.829

Review 8.  Relevance of Porcine Stroke Models to Bridge the Gap from Pre-Clinical Findings to Clinical Implementation.

Authors:  Marc Melià-Sorolla; Carlos Castaño; Núria DeGregorio-Rocasolano; Luis Rodríguez-Esparragoza; Antoni Dávalos; Octavi Martí-Sistac; Teresa Gasull
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.